Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lasa Supergenerics Limited Call Transcript 2021

Aug 17, 2021

61953_rns_2021-08-17_45063fe5-b652-4e2c-9f1b-c04c754b0946.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [452 x 69] intentionally omitted <==

Ref. No.: LASA/SE/21-22/24

Tuesday, August 17 2021

To,Corporate Services DepartmentBSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001.BSE CODE –540702 To,Corporate Services DepartmentNational Stock Exchange of India Limited“Exchange Plaza”, Plot No. C/1,G Block Bandra-Kurla Complex,Bandra (E), Mumbai – 400 051.NSE CODE: LASA

Dear Sir/Madam,

Sub. Intimation of earnings call on financial results for the quarter ended June 30, 2021

Dear Sir/Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday August 20, 2021 at 11:00 a.m IST to discuss the un-audited financial results of the Company for the quarter ended June 2021.

The details of dial number are annexed herewith.

Please take the above on your records.

THANKING YOU YOURS SINCERELY

FOR LASA SUPERGENERICS LIMITED

==> picture [471 x 68] intentionally omitted <==

NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER

==> picture [464 x 18] intentionally omitted <==

==> picture [139 x 80] intentionally omitted <==

`

Lasa Supergenerics Limited

Q1FY22 Earnings Conference Call

Friday, 20[th ] August 2021 at 11:00 a.m.

Tuesday, 17[th] August 2021 : Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the first quarter ended June 30 2021(Q1FY22).

It will organize an earnings conference call on Friday, 20[th] August 2021 @ 11:00 a.m. to discuss the Company’s Q1FY22 financial performance.

Dr. Omkar Herlekar - Chairperson & Managing Director will represent LASA Supergenerics Limited on the call.

The financial results are available on the corporate website - https://lasalabs.com.

DETAILS OF THE CONFERENCE CALL

Timing 11:00 a.m. IST on Friday, 20th August 2021
Diamond Pass Click Here
Conference dial-in Primary number 91 22 6280 1554 / 91 22 7115 8374
Local Access Number 91-7045671221
Hong Kong Local Access Number 800964448 / 852 30186877
Singapore Local Access Number 8001012045 / 65 31575746
UK Local Access Number 08081011573 / 44 2034785524
USA Local Access Number 18667462133/ 1 3233868721

About Lasa Supergenerics Limited (www.lasalabs.com/; BSE: 540702; NSE: LASA)

Incorporated in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. Our Company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to countries like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.

For more information contact:

Mr. Hitesh Wadhwani Lasa Supergenerics Ltd. Tel: 7798888147 E-mail: [email protected]